Simple generation of site-directed point mutations in the Escherichia coli chromosome using Red®/ET® Recombination
- 16k Downloads
Introducing point mutations into bacterial chromosomes is important for further progress in studies relying on functional genomics, systems- and synthetic biology, and for metabolic engineering. For many investigations, chromosomal systems are required rather than artificial plasmid based systems.
Here we describe the introduction of a single point mutation into the Escherichia coli chromosome by site-directed mutagenesis without leaving any selection marker. We used Red®/ET® Recombination in combination with rpsL counter-selection to introduce a single point mutation into the E. coli MG1655 genome, one of the widely used bacterial model strains in systems biology. The method we present is rapid and highly efficient. Since single-stranded synthetic oligonucleotides can be used for recombination, any chromosomal modification can be designed.
Chromosomal modifications performed by rpsL counter-selection may also be used for other bacteria that contain an rpsL homologue, since Red®/ET® Recombination has been applied to several enteric bacteria before.
KeywordsSingle Point Mutation Strain MG1655 Streptomycin Resistance Chromosomal Modification Introduce Point Mutation
Bacterial Artificial Chromosome
Red®/ET® Recombination is a powerful tool for the chromosomal inactivation of genes or complete operons [1, 2, 3]. This method is based on the homologous in vivo replacement of a gene/operon of any size and chosen position with a resistance cassette (e.g. a gene conferring antibiotic resistance) in a precise and specific manner by the λ-phage Redγβα recombination system and is applicable to all enteric bacteria. For certain purposes, the introduction of single point mutations is required rather than complete gene replacement or deletion, e.g. to modify a promoter or specifically inactivate the catalytic center of a certain gene product. In most cases, positive phenotypic selection for the introduced mutation is un-achievable, so that mutagenesis must be coupled to a counter-selection approach. A powerful counter-selection system based on the rpsL gene (rpsL-neo) and streptomycin selection for the introduction of point mutations into Bacterial Artificial Chromosomes (BACs) has been described , and this method was further useful for the recombination of large DNA-fragments into BACs . This counter-selection system is based on the rpsL gene encoding the S12 ribosomal protein, which is the target of streptomycin. Chromosomal mutations within rpsL are responsible for streptomycin resistance . Many E. coli strains commonly used for protein overproduction and/or metabolic engineering, including MC4100 , JM110 , Rosetta DE3 (Novagen, Darmstadt), HB101 (ATCC 33694), and TOP10 (Invitrogen, Karlsruhe) carry an altered rpsL gene conferring streptomycin resistance. The counter-selection system takes advantage of the fact that mutations within rpsL leading to streptomycin resistance are recessive in a merodiploid strain.
Here we describe a rapid method for site-directed mutagenesis of the E. coli chromosome. We used rpsL counter-selection in combination with Red®/ET® Recombination to introduce a single point mutation into the kdpA gene locus of the MG1655 strain genome. We show that rpsL counter-selection is applicable for introducing modifications into the bacterial chromosome. Single-stranded synthetic oligonucleotides can be used for recombination, so any chromosomal modification can be designed.
E. coli strains used and their genotypes
wild-type; F- lambda- ilvG rfb50 rph1
F- araD139 Δ(argF-lac) U169 rpsL150 relA1 flb-5301 fruA25 deoC1 ptsF25
F- thi rha lacZ(am) nagA kdpA4 trkA405 trkD1
F- lambda- ilvG rfb50 rph1 rpsL150 (StrR)
MG1655 rpsL150 kdpA4:rpsL-neo
F- lambda- ilvG rfb50 rph1 rpsL150 kdpA::rpsL-neo (KanR, StrS)
MG1655 rpsL150 kdpA4
F- lambda- ilvG rfb50 rph1 rpsL150 (StrR) kdpA4
In contrast to other K-12 E. coli strains (see Introduction), strain MG1655 contains the wild-type rpsL gene and is naturally sensitive to streptomycin. Therefore, an altered rpsL gene conferring streptomycin resistance was introduced first. For this purpose rpsL150 of E. coli MC4100 was amplified and recombined into E. coli MG1655 carrying plasmid pRed/ET(amp). The temperature sensitive (ts) origin of replication of plasmid pRed/ET(amp) restricts replication at 37°C. After each recombination step cells were incubated at 37°C to remove the plasmid, and the colonies obtained were tested for plasmid loss.
In general, it is not absolutely necessary to cure strains from plasmid pRed/ET(amp) after each recombination step. Since araBAD promoter activity is not completely down-regulated in the absence of arabinose, the occurrence of any rearrangement was prevented. Resistant colonies were not obtained on the control plate (cells equally treated without Red®/ET® production). The overall recombination frequency was about 4 × 10-8/μg DNA. All clones obtained were streptomycin resistant and ampicillin sensitive. The efficiency of proper recombination was 100% (i.e. no false-positives). We observed no differences between E. coli MG1655 and E. coli MG1655 rpsL150, neither in growth nor in kdpFABC transcription/KdpFABC translation fidelity (data not shown).
Next, the kdpA4-rpsL- neo cassette was replaced by a DNA-fragment containing the kdpA4 mutation, which was obtained by PCR using an E. coli TK2204 chromosomal DNA template. The DNA-fragment was recombined into E. coli MG1655 rpsL150 kdpA4:rpsL-neo carrying plasmid pRed/ET(amp). Depending on the amount of cells plated, limited background growth was visible as a kind of smear at this step. Nevertheless, single colonies were clearly visible. Several hundred clones were obtained, and about half of the number of clones observed on the recombination plate was observed on the control plate. The overall StrepR, KanS and AmpS clone yield was about 10%, indicating that the recombination frequency was about 2 × 10-7/μg DNA. The replacement of the kdpA4-rpsL- neo cassette against the mutated kdpA gene fragment (kdpA4) was tested for two clones which were StrepR, KanS and AmpS by PCR analysis. As expected, the size of the PCR products was about 150 bp confirming the loss of the kdpA4-rpsL-neo cassette (Figs. 2 and 3a).
In principle, this method should work for engineering a mutation into the chromosome using single-stranded synthetic oligonucleotides. To test this, two oligonucleotides were used for recombination, one 79 nucleotides (nt) and one 99 nt in length, consisting of 39 nt and 49 nt length homology arms, respectively, surrounding the point mutation. The recombination frequency for both oligonucleotides was observed to be about 2 × 10-7/μg DNA, comparable to that observed for double-stranded DNA. Replacement of the kdpA4-rpsL- neo cassette against the mutated kdpA gene fragment (kdpA4) was confirmed for two StrepR, KanS and AmpS clones from each recombination setup (79 nt and 99 nt oligo) by PCR analysis (Figs. 2 and 3a).
DNA sequencing confirmed the accurate homologous recombination of the fragments within the kdpA gene, and introduction of the G1033A mutation. Furthermore, strain MG1655 with the point mutation in kdpA was tested phenotypically for growth under K+-limitation. As shown in Fig. 3b, cells with a kdpA4 mutation exhibit growth defects under K+-limiting conditions (0.02 mM K+).
New approaches to introduce point mutations into bacterial chromosomes are important for advancing functional genomics and systems biology investigations as well as for metabolic engineering. In this way, mutations are introduced and copy numbers of the encoded proteins are retained. Moreover, it is important to avoid polar effects from remaining antibiotic resistance cassettes in the gene of interest.
Here we demonstrated that rpsL counter-selection in combination with Red®/ET® Recombination is an efficient approach to modify the E. coli chromosome. We introduced a single point mutation into the kdpA locus of E. coli MG1655, one of the bacterial model strains used widely in systems biological approaches. The method described here is convenient because a selectable marker is used in each step. Furthermore, there is no need for cloning the gene fragment into a special vector, which makes the method time efficient. Recombination between the two rpsL alleles is improbable, because Red®/ET® Recombination starts recombination at the ends of a linear fragment (Y. Zhang, personal communication), and the wild-type rpsL allele located on the linear PCR-fragment is flanked by about 300 bp 50 of which are responsible for precise recombination. The method that we present works with synthetic oligonucleotides as well. Thus it might also be used for the replacement of multiple nucleotides, for deletions or insertions within the gene of interest.
Other counter-selection methods have been described. The introduction of a single point mutation into the E. coli chromosome (at the galK locus), has been described using λ prophage suicide counter-selection . thyA- and galK- based counter-selection systems have been successfully applied to the modification of BACs [14, 15], and these methods allow modification of DNA without leaving a selectable marker at the modification site likewise rpsL-based counter-selection. While the rpsL marker gene is only slightly modified, these methods require complete deletion of the respective marker gene. Furthermore, in the case of rpsL counter-selection, cells can be grown in complex medium instead of in minimal medium, which speeds up the process and circumvents spontaneous mutations.
Another counter-selection method is recA- dependent, which relies on the integration and resolution of a special shuttle vector, and has been successfully applied to modify BACs [16, 17]. This method requires time-consuming restriction and ligation steps. These same time-consuming steps are necessary for the "gene gorging" method described previously , and most of the other counter-selection systems which use recognition sites for rare-cutting restriction endonucleases, like I-SceI. Nevertheless, these methods were successfully utilized for the modification of BACs, and the E. coli genome [19, 20]. Recently, counter-selection using I-SceI rare restriction sites has been applied to modify the Salmonella enteritidis genome using PCR-based recombination cassettes, thereby overcoming the disadvantages described above . Another common, simple method is sacB-based counter-selection , but this method implies a high frequency of spontaneous point mutations in the selection marker sacB, which significantly increases the background after negative selection . Likewise, spontaneous point mutations within the rpsL-neo cassette might also promote the occurrence of false-positive clones. Such false-positive clones can easily be identified by checking for streptomycin sensitivity after recombination of the rpsL-neo cassette.
We present an efficient and non-disruptive approach to introduce point mutations into the E. coli chromosome. Chromosomal modifications performed by rpsL counter-selection may also be used for enteric bacteria that contain an rpsL homologue and in which Red®/ET® Recombination is functional. Red®/ET® Recombination or analogous methods have been efficiently applied in Salmonella , Yersinia , Shigella , Citrobacter , and Serratia  species, and all of these species have a rpsL homologue. The versatility of this system illustrates its potential for furthering studies in an important clade of organisms.
Materials and methods
Plasmids and Strains
E. coli strains are listed in Tab. 1. Plasmid pRed/ET(amp) was obtained from the "Quick and Easy E. coli Gene Deletion Kit" (Gene Bridges, Heidelberg), and the rpsL-neo template DNA was obtained from the "Counter-Selection BAC Modification Kit" (Gene Bridges, Heidelberg). All oligonucleotides were obtained from Operon GmbH (Köln) in a salt-free grade.
Media and Growth Conditions
Cells were grown in LB broth  under aerobic conditions at the designated temperature. For solid media, 1.5% (w/v) agar was added. Antibiotics were used at the following final concentrations: ampicillin (50 μg/ml), carbenicillin (50 μg/ml in solid media), kanamycin (15 μg/ml), streptomycin (50 μg/ml), and tetracycline (3 μg/ml). For verification of the K+-dependent growth deficient phenotype, a phosphate buffered minimal medium was used containing variable amounts of K+ (0.02 mM and 10 mM, respectively) .
Competent cells and transformation
Transformations of cells by introduction of linear DNA-fragments for recombination were performed by electroporation according to the protocol recommended by the technical manual of the "Quick and Easy E. coli Gene Deletion Kit" (Gene Bridges, Heidelberg). Briefly, two 1.4 ml cultures of the designated strain were cultivated in 2.0 ml LidBac tubes (Eppendorf, Hamburg) in a thermomixer at 30°C. At an absorbance of 0.3 (600 nm), freshly prepared L-arabinose was added (0.35% w/v, final concentration) to one of the cultures inducing redγβα/recA expression, and expression was continued at 37°C. A control culture with no arabinose was incubated as a control. After 45 min, cells were harvested by centrifugation, washed twice with 10% (v/v) ice cold glycerol, and resuspended in a final volume of 30 μl in 10% (v/v) ice cold glycerol. DNA-fragments (400–600 ng ds-DNA, 150 ng ss-DNA) were then added to both samples, and mixtures were incubated on ice for 2 min. Subsequently, samples were transferred to electroporation cuvettes (BioRad, München), and electroporation was carried out with a MicroPulser (BioRad, München) at constant 2.5 kV for ~5 ms (Ec2 program). Cells were immediately removed from the cuvettes by mixing with 1 ml LB medium, and then incubated at 37°C for 3 h. Cells were collected by centrifugation, and all cells (~109) were plated on LB agar containing the appropriate antibiotics.
Transformations of cells by introduction of plasmids were performed with chemically (RbCl) competent cells as described elsewhere .
In vitro amplification of DNA-fragments
Linear DNA-fragments comprising either the wild-type or mutated rpsL gene (rpsL150) were obtained by polymerase chain reaction using primers rpsL_up1 (5'-CTTGACACCTTTTCGGCATCGC-3') and rpsL_down1 (5'-CGTTGTTAATTCAGGATTGTCC-3') with genomic DNA from E. coli MG1655 or MC4100, respectively, as templates. The kdpA4-rpsL-neo cassette was amplified using primers with homology arms consisting of 50 nucleotides upstream and downstream of the targeted point mutation and 24 nucleotides homologous to the rpsL-neo cassette (kdpA4-rpsL-neo sense 5'-GCGTGCTGGTCAGTAGCCTGTTTGCGGTCGTGACGACGGCGGCTTCCTGTGGCCTGGTGATGATGGCGGGATCG-3'; kdpA4-rpsL-neo antisense 5'-ACCATGCCACCGAGAGCGGTAAACGAATCATGCATCGCAATCACCGCGCTTCAGAAGAACTCGTCAAGAAGGCG-3') using the rpsL-neo template DNA (Gene Bridges, Heidelberg). For amplification of the mutated kdpA gene (kdpA4), primers that bind upstream and downstream, respectively, of the homology arms were used (counter_kdpA4_sense 5'-AGGTAAAGAGAGCCGTTTCGG-3', and counter_kdpA4_antisense 5'-ATTTGCATCAGCCACATCGGC-3'), and the DNA-fragment was obtained by PCR using genomic DNA of E. coli TK2204 as template. For further verification of the point mutation in kdpA, the targeted portion of the kdpA gene was amplified with primers kdpA2_sense (5'-CCAACGGCGCTGTGCTTTGCC-3') and kdpA2_antisense (5'-GAATAGCGCCAGTTGTTTACG-3'). For all amplifications Phusion™ polymerase (New England Biolabs, Frankfurt) was used, and the protocol recommended for this polymerase was applied (30 cycles, 10 sec 98°C, 20 sec 50°C, 15–30 sec 72°C). For large amounts of DNA, each PCR was performed in parallel several times. PCR products were separated by agarose gel electrophoresis, and DNA was isolated and concentrated by elution in a final volume of 10 μl using the MinElute Gel Extraction Kit (Qiagen, Hilden). For replacement of the kdpA4-rpsL-neo cassette by single-stranded oligonucleotides, we used oligonucleotides kdpA4_80_cassette (5'-GTAGCCTGTTTGCGGTCGTGACGACGGCGGCTTCCTGTAGCGCGGTGATTGCGATGCATGATTCGTTTACCGCTCTCGG-3') and kdpA4_100_cassette (5'-GTGCTGGTCAGTAGCCTGTTTGCGGTCGTGACGACGGCGGCTTCCTGTAGCGCGGTGATTGCGATGCATGATTCGTTTACCGCTCTCGGTGGCATGGTG-3') harboring the kdpA4 mutation. For verification of correct clones, colony PCR was performed.
We thank Sonja Kroll for excellent technical assistance. This work was financially supported by the Deutsche Forschungsgemeinschaft (Exc114/1), and the BMBF (SysMO, project 4).
- 10.Epstein W, Davies M: Potassium-dependant mutants of Escherichia coli K-12. J Bacteriol. 1970, 101: 836-843.Google Scholar
- 26.Mundy R, Petrovska L, Smollett K, Simpson N, Wilson RK, Yu J, Tu X, Rosenshine I, Clare S, Dougan G, Frankel G: Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun. 2004, 72: 2288-2302. 10.1128/IAI.72.4.2288-2302.2004.CrossRefGoogle Scholar
- 27.Rossi MS, Paquelin A, Ghigo JM, Wandersman C: Haemophore-mediated signal transduction across the bacterial cell envelope in Serratia marcescens : the inducer and the transported substrate are different molecules. Mol Microbiol. 2003, 48: 1467-1480. 10.1046/j.1365-2958.2003.03516.x.CrossRefGoogle Scholar
- 28.Sambrock J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. 1989, Cold Spring Harbor, N.Y.: Cold Spring Harbor LaboratoryGoogle Scholar
- 29.Epstein W, Kim BS: Potassium transport loci in Escherichia coli K-12. J Bacteriol. 1971, 108: 639-644.Google Scholar
- 30.Promega: Altered sites II in vitro mutagenesis system. Technical Manual. 1994Google Scholar
- 31.Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997, 277: 1453-1474. 10.1126/science.277.5331.1453.CrossRefGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.